Neo-adjuvant PIPAC and Systemic Chemotherapy in Management of Synchronous Peritoneal Metastasis From Gastric Cancer

Journal Title: Journal of Clinical Medical Research - Year 2023, Vol 4, Issue 3

Abstract

Introduction: Polycystic Ovarian Disorder (PCOD) is a prevalent endocrine illness in women of reproductive age. It has hormonal abnormalities, irregular menstrual cycles and tiny ovarian cysts. Lifestyle and food affect PCOD development and maintenance, coupled with Peritoneal metastasis from gastric cancer remains a major problem. The aim of our study is a retrospective analysis in two different groups with used PIPAC as neo-adjuvant management of synchronous peritoneal metastasis. Group A: 42 patients received as neo-adjuvant treatment 2 cycles of PIPAC (Doxorubicin 3 mgr/m2, cisplatin 10 mgr/m2) and 6 cycles of neo-adjuvant systemic chemotherapy with FLOT and we performed CRS+HIPEC (with cisplatin 80 mgr/m2, mitomycin 35 mgr/m2) for 90 min and 6 cycles of adjuvant systemic chemotherapy with FLOT. Group B: 26 patients received 4 cycles of neo-adjuvant systemic chemotherapy with FLOT, we performed CRS+HIPEC as Group A and 4 cycles of systemic chemotherapy with FLOT. For patients of Group A, the Median survival time is 46months.Group B patients had a median OS of 36 months. For patients of Group A, the Median Disease Time (DFS) was 37 months. Group B patients had a median DFS of 30 months. For each degree increase in the PCI pre score and for the same treatment group, the PCI posr score increases by 0.573 degrees. Group 2, for the same PCIpre score, have a 163% higher PCI posr score. On patients with singet ring cell adenocarcinoma there is a statistical significance difference in OS for PIPAC group. Patients of group A had a median OS of 26 months. For patients of group B, the median OS was 14 months. Morbidity and mortality in both groups are 53,4% and 4,7% for Group A and 44,5% and 5,5% for Group B respectively. The neo-adjuvant PIPAC with systemic chemotherapy might be a promising approach for patients with peritoneal metastasis from gastric cancer. PIPAC is a safe and well tolerated procedure.

Authors and Affiliations

Bohlooli M, Farmakis D, Saroyan H, Kazemi V, Noskova I, Omid R, Spiliotis J

Keywords

Related Articles

Cavernous Sinus Thrombosis as a Complication of Undiagnosed Protein Losing Enteropathy Secondary to Mixed Connective Tissue Disease: A Case Report

Background: Mixed connective tissue disease is a rare autoimmune disease that can lead to dysfunction in multiple organ systems. It has known prothrombogenic properties that typically spare the vasculature of the central...

The Genetic Discrepancy-Lynch Syndrome

Lynch syndrome is a frequently discerned hereditary cancer syndrome demonstrating the occurrence of colorectal carcinomas in around 80% subjects and endometrial cancers in nearly 60% individuals. Lynch syndrome is acco...

Presternal Scrofuloderma in a HIV Infected Patient Case Report and Discussion of the Literature Data

Scrofuloderma is a cutaneous extension of Mycobacterium tuberculosis (and rarely Mycobacterium bovis or Calmette-Guerin bacillus) from a local focus. It is a rare form of extra-pulmonary tuberculosis, starting as a painl...

Exploring the Intricacies of Encephalitis in Mosquito-Borne Diseases through Vector-Host-Pathogen Interactions: A Critical Review

Environmental changes, medication resistance and sociodemographic shifts have all contributed to a dramatic increase in vector-borne diseases in the last 40 years, impacting both people and domestic animals. Pandemics li...

Effects of Progressive Physiotherapy Along with or Without Active Bed Rest at Hospital for the Management of Chronic Low Back Pain (LBP) Patients in Bangladesh

Background: Low Back Pain (LBP) is a significant health condition globally suffered by the middle and older aged population due to its impact on work disability, absenteeism and costs. Physiotherapy with active rest and...

Download PDF file
  • EP ID EP722226
  • DOI http://dx.doi.org/10.46889/JCMR.2023.4307
  • Views 56
  • Downloads 0

How To Cite

Bohlooli M, Farmakis D, Saroyan H, Kazemi V, Noskova I, Omid R, Spiliotis J (2023). Neo-adjuvant PIPAC and Systemic Chemotherapy in Management of Synchronous Peritoneal Metastasis From Gastric Cancer. Journal of Clinical Medical Research, 4(3), -. https://europub.co.uk/articles/-A-722226